Jason explores the growing research around GLP-1 medications and their potential role in addiction treatment, including how these medications may impact cravings, dopamine signaling, reward pathways, relapse prevention, and the connection between metabolic health and substance use disorders
Semaglutide is neuro-protective and reduces -synuclein levels in the chronic MPTP mouse model of Parkinson's disease
Specific Glutathione Content: Rich in glutathione and other antioxidants
Peters, a lawyer specializing in medical malpractice and personal injury, joined Nace Law Group in 2022
Filed in 1992 and granted in 1997, these patents only listed Habener
Clinical trials demonstrate that pairing these two medications can enhance glucose control while supporting sustainable weight management without requiring significant dose adjustments to either drug